Long Term Effects of an Inpatient Pulmonary Rehabilitation Program in Patients With Pulmonary Fibrosis

September 2, 2020 updated by: Klaus Kenn, Schön Klinik Berchtesgadener Land

Long Term Effects of a 3-week Inpatient Pulmonary Rehabilitation Program in Patients With Idiopathic Pulmonary Fibrosis

There is evidence that an inpatient pulmonary rehabilitation of 3 weeks improves exercise capacity and quality of life in patients with idiopathic pulmonary fibrosis. However, there are no data available regarding long-term effects of this multimodal program. The aim of this study is to investigate the long-term impact of a rehabilitation program 3 month after finishing on exercise capacity and physical activity.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

51

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Germany
    • Bavaria
      • Schoenau Am Koenigssee, Bavaria, Germany, 83471
        • Schoen Klinik Berchtesgadener Land

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • want to start a rehabilitation program in "Schoen Klinik Berchtesgadener Land"
  • patients with idiopathic pulmonary fibrosis (vital capacity > 50% pred.)

Exclusion Criteria:

  • exacerbation in the last 4 weeks

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual care
Usual care during the whole study period without pulmonary rehabilitation. The patients will perform their normal daily life.
Active Comparator: Inpatient Rehabilitation
3-week inpatient multimodal pulmonary rehabilitation program, including daily exercise training, breathing therapy, medical treatment and psychological support. In the following 3 month, the patients will perform their normal daily life.
Procedure: Inpatient Rehabilitation
Rehabilitation program in "Schoen Klinik Berchtesgadener Land"

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Delta of 6-minute walking distance from 1 week pre rehabilitation to 3 month post rehabilitation
Time Frame: 1 week before rehabilitation to 3 month after finishing rehabilitation
1 week before rehabilitation to 3 month after finishing rehabilitation

Secondary Outcome Measures

Outcome Measure
Time Frame
Delta of physical activity level from 1 week pre rehabilitation to 3 month post rehabilitation
Time Frame: 1 week before rehabilitation to 3 month after finishing rehabilitation
1 week before rehabilitation to 3 month after finishing rehabilitation
Delta of SF36-score (questionnaire to measure quality of life) from 1 week pre to 3 month post rehabilitation
Time Frame: 1 week before rehabilitation to 3 month after finishing rehabilitation
1 week before rehabilitation to 3 month after finishing rehabilitation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Schön Klinik Berchtesgadener Land

Investigators

  • Study Director: Klaus Kenn, MD, Head physician in the department of pulmology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2013

Primary Completion (Actual)

June 1, 2016

Study Completion (Actual)

October 1, 2016

Study Registration Dates

First Submitted

January 17, 2013

First Submitted That Met QC Criteria

January 18, 2013

First Posted (Estimate)

January 21, 2013

Study Record Updates

Last Update Posted (Actual)

September 4, 2020

Last Update Submitted That Met QC Criteria

September 2, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Fibrosis2013

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Idiopathic Pulmonary Fibrosis

Clinical Trials on Inpatient Rehabilitation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe